SOURCE: Equity Markets Inc

September 23, 2011 09:00 ET

Global Situation & Resulting Influences - Research Report on Oculus Innovative Sciences, Inc. and Allergan, Inc.

MACAU--(Marketwire - Sep 23, 2011) - Today, www.EquityMarketsInc.com announced its research report highlighting Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) and Allergan, Inc. (NYSE: AGN). Full content and research is available at www.EquityMarketsInc.com/research.php?id=OCLS+AGN.

Continued confidence in long-term U.S. debt is defying S&P's recent downgrade. Treasury yields continue at their lowest levels since January 1, 2011 as the market moved to "safe investments," wary of the storm clouds ahead. Winds can change however, as a last-minute move to save the U.S. from a historic default on its debt obligations. Attentions are now turned to the situation in Europe, with the health of the Euro in the balance; bankers are looking to prevent defaults on Italian and Spanish debt.

As a result of recent credit adjustments, opportunity is being marked for investors to take advantage of equities with high-margin and specialty products. Market-wise investors are carefully watching for value within equities boasting established pipelines and excellent growth prospects. As part of this process, the following companies have been introduced with initial research reports available online.

Equity Markets has reviewed Oculus Innovative Sciences, Inc. for its current position within the healthcare industry. Oculus Innovative Sciences, Inc. develops, manufactures and markets a family of tissue care products that cure infections, and through a separate mechanism of action, enhance healing while reducing the need for antibiotics. The full research report on Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) is available here: www.EquityMarketsInc.com/research.php?id=OCLS.

Equity Markets has reviewed Allergan, Inc. for its development within the healthcare industry. Allergan, Inc. (Allergan) is a multi-specialty health care company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. The full research report on Allergan, Inc. (NYSE: AGN) is available here: www.EquityMarketsInc.com/research.php?id=AGN.

About Equity Markets
Our mission at Equity Markets is to be the best source of content and research, while educating, enlightening and informing investors. Equity Markets combines street smart analysts and professional market researchers to provide investors with detailed company profiles and market coverage.

Contact Information